Skip to content

H.R. 6664 · 118th Congress (2023–2025)

Innovation in Pediatric Drugs Act of 2023

To encourage innovation in the development of pediatric drugs, and for other purposes.

CRS summary not yet available.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 6664’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Anna G. Eshoo (D-CA-16)
Cosponsors
9 cosponsors

1 original · 8 later

1 R · 8 D

  1. Rep. Michael T. McCaul (R-TX-10)· Original · Dec 7, 2023
  2. Rep. Darren Soto (D-FL-9)· Later · Jan 29, 2024
  3. Rep. Kim Schrier (D-WA-8)· Later · Feb 29, 2024
  4. Rep. Lori Trahan (D-MA-3)· Later · Apr 29, 2024
  5. Rep. Donald G. Davis (D-NC-1)· Later · May 6, 2024
  6. Rep. Nanette Diaz Barragán (D-CA-44)· Later · May 8, 2024
  7. Rep. Steve Cohen (D-TN-9)· Later · May 14, 2024
  8. Rep. Debbie Wasserman Schultz (D-FL-25)· Later · May 21, 2024
  9. Rep. Paul Tonko (D-NY-20)· Later · May 23, 2024
Policy area
Health
Subjects
  • Child health
  • Congressional oversight
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Government studies and investigations
  • Health programs administration and funding
  • Medical research
  • Prescription drugs
  • 1 more
    • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Dec 7, 2023 – Dec 8, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Dec 7, 2023
  2. HouseHealthReferred Dec 8, 2023
    1. Feb 29, 2024 · Hearing

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Innovation in Pediatric Drugs Act of 2023

    Display title, Short title · Introduced in House

  2. To encourage innovation in the development of pediatric drugs, and for other purposes.

    Official title · Introduced in House